Literature DB >> 21294237

Gut-brain signalling: how lipids can trigger the gut.

Danna M Breen1, Clair S Yang, Tony K T Lam.   

Abstract

The gut plays a unique role in the metabolic defence against energy excess and glucose imbalance. Nutrients, such as lipids, enter the small intestine and activate sensing mechanisms to maintain energy and glucose homeostasis. It is clear that a lipid-induced gut-brain axis exists and that cholecystokinin and a neuronal network are involved, yet the underlying mechanisms in gut lipid sensing that regulate homeostasis remain largely unknown. In parallel, studies underscore the importance of enzymes involved in lipid metabolism within the brain, such as adenosine monophosphate -activated protein kinase, to maintain homeostasis. In this review, we will first examine what is known regarding the mechanisms involved in this lipid-induced gut-brain neuronal axis that regulate food intake and hepatic glucose production. We will also discuss how enzymes that govern brain lipid metabolism could potentially reveal how lipids trigger the gut, and that both the gut and brain may share common biochemical pathways to sense lipids.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294237     DOI: 10.1002/dmrr.1160

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  5 in total

Review 1.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

2.  Identification of optimal reference genes for RT-qPCR in the rat hypothalamus and intestine for the study of obesity.

Authors:  B Li; E K Matter; H T Hoppert; B E Grayson; R J Seeley; D A Sandoval
Journal:  Int J Obes (Lond)       Date:  2013-05-24       Impact factor: 5.095

3.  Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity.

Authors:  Su-Hyoun Chon; John D Douglass; Yin Xiu Zhou; Nashmia Malik; Joseph L Dixon; Anita Brinker; Loredana Quadro; Judith Storch
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

4.  Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.

Authors:  Erin D Roe; Bindu Chamarthi; Philip Raskin
Journal:  J Diabetes Res       Date:  2015-04-28       Impact factor: 4.011

Review 5.  Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes.

Authors:  Danna M Breen; Brittany A Rasmussen; Clémence D Côté; V Margaret Jackson; Tony K T Lam
Journal:  Diabetes       Date:  2013-09       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.